Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung Ultrasound for the Detection of Radiologic Progression of Interstitial Lung Abnormalities in Patients with Rheumatoid Arthritis: Response to Gao et al.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Evaluating machine learning tools to assist title and abstract screening in systematic literature reviews: a report based on the EULAR RA Management Recommendations Task Force.

Annals of the rheumatic diseases·2026
Same author

The prevalence of interstitial lung disease in rheumatoid arthritis: a systematic review.

Rheumatology advances in practice·2026
Same author

Bone health in young adults with inflammatory arthritis: assessment of associated factors of low bone mineral density.

Archives of osteoporosis·2026
Same author

Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis.

Annals of the rheumatic diseases·2026
Same author

The management of spondyloarthritis in sub-Saharan Africa: a real-world cohort from Kinshasa, Democratic Republic of the Congo.

Rheumatology advances in practice·2026
Same journal

Alterations in systemic and skeletal muscle myostatin regulation are most prominent at disease onset and associate with muscle-related outcomes in idiopathic inflammatory myopathies.

Arthritis research & therapy·2026
Same journal

Plasma proteome differences between giant cell arteritis and polymyalgia rheumatica: a pilot study.

Arthritis research & therapy·2026
Same journal

Elucidating the mechanism of taurine in alleviating osteoarthritis progression based on bioinformatics, machine learning algorithm, and experimental validation.

Arthritis research & therapy·2026
Same journal

Discovery of biomarkers for primary Sj ögren's syndrome based on multi-omics data, construction of diagnostic models, and clinical correlation analysis.

Arthritis research & therapy·2026
Same journal

Identification of distinct subgroups in Chinese patients with Behçet's syndrome via cluster analysis of immune cells and clinical features.

Arthritis research & therapy·2026
Same journal

Artemisinin increases susceptibility to ferroptosis of fibroblast-like synoviocytes in rheumatoid arthritis.

Arthritis research & therapy·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

Transcranial Direct Current Stimulation and Simultaneous Functional Magnetic Resonance Imaging
13:35

Transcranial Direct Current Stimulation and Simultaneous Functional Magnetic Resonance Imaging

Published on: April 27, 2014

Translating co-stimulation blockade into clinical practice.

Rene Westhovens1, Patrick Verschueren

  • 1Department of Rheumatology, University Hospitals KU Leuven, Herestraat, B-3000 Leuven, Belgium. rene.westhovens@uz.kuleuven.be

Arthritis Research & Therapy
|November 26, 2008
PubMed
Summary
This summary is machine-generated.

Abatacept shows promise as a rheumatoid arthritis treatment alternative. Further research is needed to compare its effectiveness, safety, and patient-centered outcomes against other biologics for optimizing care.

More Related Videos

Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation
09:52

Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation

Published on: February 23, 2020

Deep Brain Stimulation with Simultaneous fMRI in Rodents
11:09

Deep Brain Stimulation with Simultaneous fMRI in Rodents

Published on: February 15, 2014

Related Experiment Videos

Last Updated: Jun 28, 2026

Transcranial Direct Current Stimulation and Simultaneous Functional Magnetic Resonance Imaging
13:35

Transcranial Direct Current Stimulation and Simultaneous Functional Magnetic Resonance Imaging

Published on: April 27, 2014

Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation
09:52

Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation

Published on: February 23, 2020

Deep Brain Stimulation with Simultaneous fMRI in Rodents
11:09

Deep Brain Stimulation with Simultaneous fMRI in Rodents

Published on: February 15, 2014

Area of Science:

  • Immunology
  • Rheumatology
  • Pharmacology

Background:

  • Current data suggest abatacept is a viable alternative biologic for rheumatoid arthritis.
  • Differences in effectiveness, safety, and patient-centered outcomes among biologics may exist in real-world practice.
  • Optimal treatment strategies after failure of a first tumor necrosis factor blocker are not well-defined.

Purpose of the Study:

  • To highlight the potential of abatacept as a rheumatoid arthritis treatment.
  • To emphasize the need for further investigation into patient-centered outcomes and safety profiles of biologics.
  • To explore the optimal sequencing of biologic therapies after initial treatment failure.

Main Methods:

  • Review of current clinical trial and open-label extension data for abatacept in rheumatoid arthritis.
  • Discussion of existing knowledge gaps regarding comparative effectiveness and safety of different biologics.
  • Identification of areas requiring further prospective studies and registry data.

Main Results:

  • Abatacept is presented as a potentially effective alternative biologic for rheumatoid arthritis.
  • The study underscores the need to evaluate patient-centered outcomes and safety profiles in real-world settings.
  • Lack of direct comparative studies for treatment strategies post-tumor necrosis factor blocker failure is noted.

Conclusions:

  • Abatacept offers a valuable option, but comparative data on effectiveness and safety are crucial for optimizing patient care.
  • Further research, including prospective studies, is essential to guide treatment decisions for rheumatoid arthritis and other immune-mediated diseases.
  • Targeted therapies, like co-stimulation blockade, present new treatment avenues for diverse patient populations.